Stereotaxis, Inc. (STXS)
After hours:
| Previous Close | 1.9200 |
| Open | 1.9300 |
| Bid | 1.8900 x 900 |
| Ask | 2.2700 x 900 |
| Day's Range | 1.8800 - 1.9500 |
| 52 Week Range | 1.4000 - 3.2900 |
| Volume | |
| Avg. Volume | 193,662 |
| Market Cap | 162.54M |
| Beta (5Y Monthly) | 1.55 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.2600 |
| Earnings Date | Nov 11, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 4.50 |
GlobeNewswireStereotaxis to Report Third Quarter 2024 Financial Results on November 11, 2024
ST. LOUIS, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial results for its 2024 third quarter on Monday, November 11, 2024 at the close of the U.S. financial markets. The Company will host a conference call and webcast at 4:30 p.m. ET that day to discuss the Company’s results and corporate developments. What: Stereotaxis third quarter 2024
- GlobeNewswire
Stereotaxis Technology to be Featured at Annual Meeting of the Society for Cardiac Robotic Navigation
ST. LOUIS, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will participate in the Society for Cardiac Robotic Navigation’s Annual Meeting taking place October 28-29 in Lisbon, Portugal. The global physician-led Society for Cardiac Robotic Navigation (SCRN) is dedicated to establishing a community and platform for users of robotic technologies in cardiology. The
